Publications

  • Musie Ghebremichael, Haben Michael. Comparison of the binormal and Lehman receiver operating characteristic curves. Communications in Statistics-Simulation and Computation. 2022; 1-14.

  • Eliezer Bose, Elijah Paintsil, Musie Ghebremichael. Minimum redundancy maximal relevance gene selection of apoptosis pathway genes in peripheral blood mononuclear cells of HIV-infected patients with antiretroviral therapy-associated mitochondrial toxicity. BMC Med Genomics. 2021 Dec 1;14(1):285.

  • Melissa Innerst, Jack D. Tubbs, Musie Ghebremichael. A Comparison of the Lehmann and GLM ROC Models. Science Journal of Applied Mathematics and Statistics. 2021; 9(2): 57 - 72 .

  • Gopalakrishnan V, Bose E, Nair U, Gheng Y, Ghebremichael M. Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection BMC Infect Dis. 2020 Oct 15;20(1):756.

  • Lee JS, Paintsil E, Gopalakrishnan V, Ghebremichael M. A comparison of machine learning techniques for classification of HIV patients with antiretroviral therapy-induced mitochondrial toxicity from those without mitochondrial toxicity. BMC Med Res Methodol. 2019 Nov 27;19(1):216.

  • Ghebremichael M, Michael H, Tubbs J, Paintsil E. Comparing the Diagnostics Accuracy of CD4+ T-Lymphocyte Count and Percent as a Surrogate Markers of Pediatric HIV Disease. J Math Stat. 2019;15(1):55-64.

  • Michael H, Tian L, and Ghebremichael M. The ROC Curve for Cohort Designs. Biostatistics. 2019 Jul 1;20(3):433-451

  • Ghebremichael M, Habtemicael S. Effect of Tuberculosis on Immune Restoration among HIV-Infected Patients Receiving Antiretroviral Therapy. Journal of Applied Statistics 2018; 45(13). 2357-2364.

  • Ghebremichael M. Joint Modeling of Correlated Binary Outcomes. HIV-1 and HSV-2 co-infection. Journal of Applied Statistics. 2015; 42(10); 2180-2191.

  • Ghebremichael M. Nonparametric estimation of mean residual life function. Lifetime Data Anal 2009;15(1):107-19.


View the complete list of publications at Harvard Catalyst.